F. Friedlos et al., GENE-DIRECTED ENZYME PRODRUG THERAPY - QUANTITATIVE BYSTANDER CYTOTOXICITY AND DNA-DAMAGE INDUCED BY CB1954 IN CELLS EXPRESSING BACTERIAL NITROREDUCTASE, Gene therapy, 5(1), 1998, pp. 105-112
Citations number
20
Categorie Soggetti
Biothechnology & Applied Migrobiology","Genetics & Heredity",Biology,"Medicine, Research & Experimental
Clones of human colon carcinoma (WiDr), ovarian carcinoma (SK-OV-3), a
nd Chinese hamster V79 cells expressing the nitroreductase enzyme (NR)
from E. coli B were 52-, 225- and 177-fold respectively more sensitiv
e to a 24-h incubation with the prodrug 5-(aziridin-1-yl)-2,4-dinitrob
enzamide (CB1954) than the parent lines. The IC(50)s of non-NR-express
ing bystander cells were measured in the presence of differing proport
ions of NR-expressing cells. The shift in IC50 was used to calculate a
value for the bystander effect, termed the transmission efficiency (T
E), which is the decrease in IC50 due to bystander effect as a percent
age of the maximum decrease possible. The percentage of NR-expressing
cells for which the TE was 50%, (the TE50) is a single datum of bystan
der efficacy. WiDr and V79 cell lines, had a similar TE50 of approxima
tely 2%, SK-OV-3 gave a lower value of 0.3%. These TE50 correlate with
concentrations of cytosolic NR activity, which is distinguished from
endogenous DT diaphorase activity by kinetic differences. A novel meth
od is described which enables both DNA crosslinks and drug-induced sin
gle-strand breaks to be simultaneously quantified in a sedimentation a
ssay. Using this technique, bystander DNA damage was demonstrated in V
79 cells, of approximately 50% of that in activator cells.